141 related articles for article (PubMed ID: 37453261)
1. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.
Brocard G; Casey R; Dufay N; Marignier R; Michel L; Hisbergues M; Ayrignac X; Lehmann S; Thouvenot E; Gallot G; Collongues N; Herpe YE; Lebrun-Frenay C; Cotton F; De Sèze J; Guillemin F; Moreau T; Pelletier J; Stankoff B; Vukusic S; Zephir H; Laplaud D;
Mult Scler Relat Disord; 2023 Sep; 77():104872. PubMed ID: 37453261
[TBL] [Abstract][Full Text] [Related]
2. Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.
Vukusic S; Casey R; Rollot F; Brochet B; Pelletier J; Laplaud DA; De Sèze J; Cotton F; Moreau T; Stankoff B; Fontaine B; Guillemin F; Debouverie M; Clanet M
Mult Scler; 2020 Jan; 26(1):118-122. PubMed ID: 30541380
[TBL] [Abstract][Full Text] [Related]
3. OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.
Cotton F; Kremer S; Hannoun S; Vukusic S; Dousset V;
J Neuroradiol; 2015 Jun; 42(3):133-40. PubMed ID: 25660217
[TBL] [Abstract][Full Text] [Related]
4. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.
Wilson S; Calocer F; Rollot F; Fauvernier M; Remontet L; Tron L; Vukusic S; Le Page E; Debouverie M; Ciron J; Ruet A; De Sèze J; Zephir H; Moreau T; Lebrun-Frénay C; Laplaud DA; Clavelou P; Labauge P; Berger E; Pelletier J; Heinzlef O; Thouvenot E; Camdessanché JP; Leray E; Dejardin O; Defer G
Lancet Reg Health Eur; 2023 Jan; 24():100542. PubMed ID: 36426377
[TBL] [Abstract][Full Text] [Related]
5. The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics.
Vukusic S; Bourre B; Casey R; Deiva K; Guennoc AM; Lebrun-Frenay C; Leray E; Rollot F; Benyahya L; Girod C; Marignier R; Maillart E
Mult Scler; 2024 Feb; 30(2):216-226. PubMed ID: 38205811
[TBL] [Abstract][Full Text] [Related]
6. Update on brain MRI for the diagnosis and follow-up of MS patients.
Brisset JC; Vukusic S; Cotton F;
Presse Med; 2021 Jun; 50(2):104067. PubMed ID: 33989722
[TBL] [Abstract][Full Text] [Related]
7. Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
Vukusic S; Rollot F; Casey R; Pique J; Marignier R; Mathey G; Edan G; Brassat D; Ruet A; De Sèze J; Maillart E; Zéphir H; Labauge P; Derache N; Lebrun-Frenay C; Moreau T; Wiertlewski S; Berger E; Moisset X; Rico-Lamy A; Stankoff B; Bensa C; Thouvenot E; Heinzlef O; Al-Khedr A; Bourre B; Vaillant M; Cabre P; Montcuquet A; Wahab A; Camdessanché JP; Tourbah A; Guennoc AM; Hankiewicz K; Patry I; Nifle C; Maubeuge N; Labeyrie C; Vermersch P; Laplaud DA;
JAMA Neurol; 2020 Jan; 77(1):94-102. PubMed ID: 31479149
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality.
Rollot F; Uhry Z; Dantony E; Vukusic S; Debouverie M; Le Page E; Ciron J; Ruet A; De Sèze J; Zéphir H; Labauge P; Defer G; Lebrun-Frenay C; Moreau T; Laplaud DA; Berger E; Clavelou P; Pelletier J; Thouvenot E; Heinzlef O; Camdessanche JP; Fauvernier M; Remontet L; Leray E
Neurology; 2023 Dec; 101(24):e2483-e2496. PubMed ID: 37827849
[TBL] [Abstract][Full Text] [Related]
9. Improving the detection of new lesions in multiple sclerosis with a cascaded 3D fully convolutional neural network approach.
Salem M; Ryan MA; Oliver A; Hussain KF; Lladó X
Front Neurosci; 2022; 16():1007619. PubMed ID: 36507318
[TBL] [Abstract][Full Text] [Related]
10. The Norwegian Multiple Sclerosis Registry and Biobank.
Myhr KM; Grytten N; Torkildsen Ø; Wergeland S; Bø L; Aarseth JH
Acta Neurol Scand; 2015; 132(199):24-8. PubMed ID: 26046555
[TBL] [Abstract][Full Text] [Related]
11. Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis.
Roos I; Leray E; Casey R; Horakova D; Havrdova E; Izquierdo G; Madueño SE; Patti F; Edan G; Debouverie M; Pelletier J; Ozakbas S; Amato MP; Clavelou P; Grammond P; Boz C; Buzzard K; Skibina O; Ciron J; Gerlach O; Grand'Maison F; Lechner-Scott J; Malpas C; Butzkueven H; Vukusic S; Kalincik T;
Neurology; 2021 Aug; 97(9):e869-e880. PubMed ID: 34193589
[TBL] [Abstract][Full Text] [Related]
12. MRI to detect and localize the area postrema in multiple sclerosis: The role of 3D-DIR and 3D-FLAIR.
Farges V; Hannoun S; Benini T; Marignier R; Cotton F
J Neuroimaging; 2021 Jul; 31(4):701-705. PubMed ID: 33930239
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI.
Roca P; Attye A; Colas L; Tucholka A; Rubini P; Cackowski S; Ding J; Budzik JF; Renard F; Doyle S; Barbier EL; Bousaid I; Casey R; Vukusic S; Lassau N; Verclytte S; Cotton F; ; ; ;
Diagn Interv Imaging; 2020 Dec; 101(12):795-802. PubMed ID: 32651155
[TBL] [Abstract][Full Text] [Related]
14. Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry.
Simoneau G; Jiang X; Rollot F; Tian L; Copetti M; Guéry M; Ruiz M; Vukusic S; de Moor C; Pellegrini F;
Mult Scler J Exp Transl Clin; 2022; 8(3):20552173221116591. PubMed ID: 35959484
[TBL] [Abstract][Full Text] [Related]
15. The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
Steinemann N; Kuhle J; Calabrese P; Kesselring J; Disanto G; Merkler D; Pot C; Ajdacic-Gross V; Rodgers S; Puhan MA; von Wyl V;
BMC Neurol; 2018 Aug; 18(1):111. PubMed ID: 30103695
[TBL] [Abstract][Full Text] [Related]
16. Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
Rollot F; Fauvernier M; Uhry Z; Vukusic S; Bossard N; Remontet L; Leray E;
Neurology; 2021 Jul; 97(4):e403-e413. PubMed ID: 34011577
[TBL] [Abstract][Full Text] [Related]
17. Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner.
Oh J; Gagné-Brosseau MS; Guenette M; Larochelle C; Lemieux F; Menon S; Morrow SA; Poliquin-Lasnier L; Roy-Hewitson C; Rush C; Trudelle AM; Giacomini PS
Can J Neurol Sci; 2018 May; 45(3):304-312. PubMed ID: 29756588
[TBL] [Abstract][Full Text] [Related]
18. The Norwegian Multiple Sclerosis Registry and Biobank.
Myhr KM; Grytten N; Aarseth JH
Acta Neurol Scand Suppl; 2012; (195):20-3. PubMed ID: 23278652
[TBL] [Abstract][Full Text] [Related]
19. Determinants of therapeutic lag in multiple sclerosis.
Roos I; Leray E; Frascoli F; Casey R; Brown JWL; Horakova D; Havrdova EK; Debouverie M; Trojano M; Patti F; Izquierdo G; Eichau S; Edan G; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grammond P; Ciron J; Ruet A; Ozakbas S; De Seze J; Louapre C; Zephir H; Sá MJ; Sola P; Ferraro D; Labauge P; Defer G; Bergamaschi R; Lebrun-Frenay C; Boz C; Cartechini E; Moreau T; Laplaud D; Lechner-Scott J; Grand'Maison F; Gerlach O; Terzi M; Granella F; Alroughani R; Iuliano G; Van Pesch V; Van Wijmeersch B; Spitaleri D; Soysal A; Berger E; Prevost J; Aguera-Morales E; McCombe P; Castillo Triviño T; Clavelou P; Pelletier J; Turkoglu R; Stankoff B; Gout O; Thouvenot E; Heinzlef O; Sidhom Y; Gouider R; Csepany T; Bourre B; Al Khedr A; Casez O; Cabre P; Montcuquet A; Wahab A; Camdessanche JP; Maurousset A; Patry I; Hankiewicz K; Pottier C; Maubeuge N; Labeyrie C; Nifle C; Coles A; Malpas CB; Vukusic S; Butzkueven H; Kalincik T
Mult Scler; 2021 Oct; 27(12):1838-1851. PubMed ID: 33423618
[TBL] [Abstract][Full Text] [Related]
20. [Cost of multiple sclerosis in France].
Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
